Doctors’ role in drug studies criticized
Monday, May 31st, 2010We recommend:
Some commend drugs, guarantee for studies but don’t see raw numbers
Richard Page thinks Multaq is an first-class new dose for treating atrial fibrillation, a character of maverick pulse that affects more than 2 1000000 Americans.
And Page, chair of the section of medicament at the University of Wisconsin School of Medicine and Public Health, should cognize. He co-authored a gravid, external cogitation that led to the dose’s commendation by the Food and Drug Administration end year, a movement that could bastardly hundreds of millions in sales for Sanofi-Aventis, the society that makes the dose.